	Revenu Net		Date
Acadia Pharmaceuticals	USD 273.57M	201.79M	2025-12
Agios Pharmaceuticals	USD -108.04M	4.61M	2025-12
Alnylam Pharmaceuticals	USD 186.42M	64.66M	2025-12
BioCryst Pharmaceuticals	USD -88.88M	74.85M	2024-12
BioMarin Pharmaceutical	USD -46.57M	15.83M	2025-12
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Immunic	USD -24.37M	2.99M	2024-09
Insmed	USD -328.48M	41.54M	2025-12
Ionis Pharmaceuticals	USD -229M	100.39M	2025-12
Karyopharm Therapeutics	USD -30.78M	1.29M	2024-12
Kyowa Hakko Kirin	JPY 34.44B	18.16B	2025-12
MacroGenics	USD 16.82M	53.07M	2025-09
Moderna	USD -200M	625M	2025-09
Neurocrine Biosciences	USD 209.5M	102M	2025-09
PTC Therapeutics	USD -134.96M	150.86M	2025-12
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Regeneron Pharmaceuticals	USD 844.6M	615.4M	2025-12
Sarepta Therapeutics	USD -412.23M	232.28M	2025-12
Ultragenyx Pharmaceutical	USD -129M	51.41M	2025-12
Vertex Pharmaceuticals	USD 1.19B	108.2M	2025-12
Xoma	USD -17.24M	33.23M	2024-09

Ultragenyx Pharmaceutical Revenu Net - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.